Pharmaceuticals

The development of novel and innovative medicinal products makes a decisive contribution to medical progress. At the same time, the pharmaceutical market is one of the most dynamic and, due to its high level of regulation, one of the most complex areas of healthcare. In Germany, as in other countries, pharmaceutical companies generally operate in highly regulated markets shaped by the requirements of social health insurance funds or government institutions. Key issues include market access, the availability of new therapies to patients, pricing, volume regulation and benefit assessment.